Central, local, or hybrid? Designing smarter depot strategies for clinical trials
The traditional debate around central depots vs domestic supply is now giving way to more flexible models, helping sponsors navigate complexity better while controlling costs, according to Sharp Clinical’s Mike MacNeir and Lindsay Moir.
